First Time Loading...

Shanghai Fosun Pharmaceutical Group Co Ltd
SSE:600196

Watchlist Manager
Shanghai Fosun Pharmaceutical Group Co Ltd Logo
Shanghai Fosun Pharmaceutical Group Co Ltd
SSE:600196
Watchlist
Price: 24.12 CNY 1.9% Market Closed
Updated: May 6, 2024

Wall Street
Price Targets

Price Targets Summary
Shanghai Fosun Pharmaceutical Group Co Ltd

Wall Street analysts forecast Shanghai Fosun Pharmaceutical Group Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shanghai Fosun Pharmaceutical Group Co Ltd is 30.54 CNY with a low forecast of 24.75 CNY and a high forecast of 39.9 CNY.

Lowest
Price Target
24.75 CNY
3% Upside
Average
Price Target
30.54 CNY
27% Upside
Highest
Price Target
39.9 CNY
65% Upside
Shanghai Fosun Pharmaceutical Group Co Ltd Competitors:
Price Targets
HIKAL
Hikal Ltd
13% Upside
INVA
Innoviva Inc
0% Upside
300401
Zhejiang Garden Bio-chemical High-tech Co Ltd
28% Upside
FULC
Fulcrum Therapeutics Inc
78% Upside
MEDCL
Medincell SA
21% Upside
3613
Beijing Tong Ren Tang Chinese Medicine Co Ltd
63% Upside
002422
Sichuan Kelun Pharmaceutical Co Ltd
21% Upside
4016
Middle East Pharmaceutical Industries Company SJSC
28% Downside

Revenue
Forecast

Revenue Estimate
Shanghai Fosun Pharmaceutical Group Co Ltd

For the last 8 years the compound annual growth rate for Shanghai Fosun Pharmaceutical Group Co Ltd's revenue is 16%. The projected CAGR for the next 3 years is 8%.

16%
Past Growth
8%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Shanghai Fosun Pharmaceutical Group Co Ltd

For the last 8 years the compound annual growth rate for Shanghai Fosun Pharmaceutical Group Co Ltd's operating income is -1%. The projected CAGR for the next 3 years is 28%.

-1%
Past Growth
28%
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Net Income
Forecast

Net Income Estimate
Shanghai Fosun Pharmaceutical Group Co Ltd

For the last 8 years the compound annual growth rate for Shanghai Fosun Pharmaceutical Group Co Ltd's net income is 0%. The projected CAGR for the next 3 years is 18%.

0%
Past Growth
18%
Estimated Growth
Estimates Accuracy
10%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shanghai Fosun Pharmaceutical Group Co Ltd's stock price target?
Price Target
30.54 CNY

According to Wall Street analysts, the average 1-year price target for Shanghai Fosun Pharmaceutical Group Co Ltd is 30.54 CNY with a low forecast of 24.75 CNY and a high forecast of 39.9 CNY.

What is Shanghai Fosun Pharmaceutical Group Co Ltd's Revenue forecast?
Projected CAGR
8%

For the last 8 years the compound annual growth rate for Shanghai Fosun Pharmaceutical Group Co Ltd's revenue is 16%. The projected CAGR for the next 3 years is 8%.

What is Shanghai Fosun Pharmaceutical Group Co Ltd's Operating Income forecast?
Projected CAGR
28%

For the last 8 years the compound annual growth rate for Shanghai Fosun Pharmaceutical Group Co Ltd's operating income is -1%. The projected CAGR for the next 3 years is 28%.

What is Shanghai Fosun Pharmaceutical Group Co Ltd's Net Income forecast?
Projected CAGR
18%

For the last 8 years the compound annual growth rate for Shanghai Fosun Pharmaceutical Group Co Ltd's net income is 0%. The projected CAGR for the next 3 years is 18%.